Antonios P Antoniadis
Overview
Explore the profile of Antonios P Antoniadis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
653
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karakasis P, Theofilis P, Patoulias D, Vlachakis P, Antoniadis A, Fragakis N
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076813
The global rise in diabetes prevalence has significantly contributed to the increasing burden of atherosclerotic cardiovascular disease (ASCVD), a leading cause of morbidity and mortality in this population. Diabetes accelerates...
2.
Karakasis P, Lefkou E, Pamporis K, Farmakis D, Patoulias D, Antoniadis A, et al.
Eur J Heart Fail
. 2025 Mar;
PMID: 40064512
Aims: Clonal haematopoiesis (CH) is recognized as a significant risk factor for various non-haematologic conditions, including cardiovascular diseases. However, recent studies examining its relationship with heart failure (HF) have reported...
3.
Karakasis P, Theofilis P, Vlachakis P, Korantzopoulos P, Patoulias D, Antoniadis A, et al.
Int J Mol Sci
. 2025 Jan;
26(1.
PMID: 39796066
Atrial fibrosis is a hallmark of atrial cardiomyopathy and plays a pivotal role in the pathogenesis of atrial fibrillation (AF), contributing to its onset and progression. The mechanisms underlying atrial...
4.
Papadopoulos K, Ikonomidis I, Coisne A, Ozden Kayhan O, Tzikas A, Fragakis N, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518589
Transesophageal echocardiography (TEE) is a vital diagnostic tool in clinical practice, particularly in transcatheter interventions where it aids in both pre-operative planning and intra-operative guidance. Traditional TEE probes often require...
5.
Mouselimis D, Bakogiannis C, Tsarouchas A, Papadopoulos C, Theofilogiannakos E, Pagourelias E, et al.
Hellenic J Cardiol
. 2024 Nov;
PMID: 39510249
Objective: Treating iron deficiency (ID) with ferric carboxymaltose (FCM) in patients with heart failure with reduced ejection fraction (HFrEF) enhances morbidity, quality of life (QoL), and exercise capacity. Methods: In...
6.
Bakogiannis C, Mouselimis D, Tsarouchas A, Papadopoulos C, Theofillogiannakos E, Lechat E, et al.
ESC Heart Fail
. 2023 Jan;
10(2):1184-1192.
PMID: 36647691
Aims: The Iron Intravenous Therapy in Reducing the burden of Severe Arrhythmias in HFrEF (RESAFE-HF) registry study aims to provide real-word evidence on the impact of intravenous ferric carboxymaltose (FCM)...
7.
Lazaridis C, Bakogiannis C, Mouselimis D, Tsarouchas A, Antoniadis A, Triantafyllou K, et al.
Health Informatics J
. 2022 Nov;
28(4):14604582221139053.
PMID: 36398411
Atrial fibrillation (AF) is the most common arrhythmia. myAlgos is an mHealth disease management system consisting of physician-oriented platform and patient-oriented smartphone app. Our purpose was to assess the usability...
8.
Lagos I, Dadoush G, Deligiannidis A, Antoniadis A, Kanonidis I, Timotheadou E, et al.
Hellenic J Cardiol
. 2022 Nov;
71:61-63.
PMID: 36328159
No abstract available.
9.
Fragakis N, Antoniadis A, Sotiriadou M, Virgiliou C, Ballauri I, Gika H, et al.
Int J Cardiol
. 2022 Jun;
363:43-48.
PMID: 35716941
Background: In syncopal patients without underlying structural disease, we sought to investigate the association of Adenosine Plasma Levels (ADP) with the clinical presentation of neurally mediated syncope (NMS) and the...
10.
Charitakis E, Metelli S, Karlsson L, Antoniadis A, Rizas K, Liuba I, et al.
BMC Med
. 2022 May;
20(1):193.
PMID: 35637488
Background: There is no consensus on the most efficient catheter ablation (CA) strategy for patients with atrial fibrillation (AF). The objective of this study was to compare the efficacy and...